LivaNova Reports Third Quarter 2019 Results

Go back to LivaNova Reports Third Quarter 2019 Results

Livanova (LIVN) PT Lowered to $88 at Needham & Company

October 30, 2019 12:25 PM EDT

Needham & Company analyst Mike Matson lowered the price target on Livanova (NASDAQ: LIVN) to $88.00 (from $91.00) while maintaining a Buy rating.

Matson commented, "LIVN's 3Q19 revenue missed and EPS beat consensus and management reiterated its 2019 guidance. Organic revenue growth adjusted for the end of a... More

LivaNova plc (LIVN) Tops Q3 EPS by 9c, Revenues Miss; Offers FY19 Outlook

October 30, 2019 6:14 AM EDT

LivaNova plc (NASDAQ: LIVN) reported Q3 EPS of $0.84, $0.09 better than the analyst estimate of $0.75. Revenue for the quarter came in at $268.6 million versus the consensus estimate of $273.93 million.

"The third quarter of 2019 showed further sequential momentum in our U.S. Neuromodulation... More